£3.3M
The Stevenage enterprise raised the capital from Longwall Ventures and a syndicate of backers to fund trials and product development.
"Advanced therapy manufacturing is hindered by out of date, inadequate manufacturing technologies,"
M
MicrofluidX—Stevenage, UKLongwall Ventures + 5 others
